IPSEN (IPN.PA) Fundamental Analysis & Valuation

EPA:IPN • FR0010259150

Current stock price

170.8 EUR
+8.1 (+4.98%)
Last:

This IPN.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. IPN.PA Profitability Analysis

1.1 Basic Checks

  • In the past year IPN was profitable.
  • In the past year IPN had a positive cash flow from operations.
  • Each year in the past 5 years IPN has been profitable.
  • Each year in the past 5 years IPN had a positive operating cash flow.
IPN.PA Yearly Net Income VS EBIT VS OCF VS FCFIPN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • IPN has a Return On Assets of 11.21%. This is in the better half of the industry: IPN outperforms 76.47% of its industry peers.
  • IPN's Return On Equity of 17.93% is fine compared to the rest of the industry. IPN outperforms 68.63% of its industry peers.
  • IPN's Return On Invested Capital of 21.54% is amongst the best of the industry. IPN outperforms 84.31% of its industry peers.
Industry RankSector Rank
ROA 11.21%
ROE 17.93%
ROIC 21.54%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IPN.PA Yearly ROA, ROE, ROICIPN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

1.3 Margins

  • Looking at the Profit Margin, with a value of 13.25%, IPN is in line with its industry, outperforming 56.86% of the companies in the same industry.
  • IPN's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 25.32%, IPN is in the better half of the industry, outperforming 62.75% of the companies in the same industry.
  • In the last couple of years the Operating Margin of IPN has remained more or less at the same level.
  • With an excellent Gross Margin value of 81.66%, IPN belongs to the best of the industry, outperforming 86.27% of the companies in the same industry.
  • In the last couple of years the Gross Margin of IPN has remained more or less at the same level.
Industry RankSector Rank
OM 25.32%
PM (TTM) 13.25%
GM 81.66%
OM growth 3Y-3.38%
OM growth 5Y-1.48%
PM growth 3Y-18.1%
PM growth 5Y-11.16%
GM growth 3Y-0.97%
GM growth 5Y-0.21%
IPN.PA Yearly Profit, Operating, Gross MarginsIPN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. IPN.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IPN is creating value.
  • IPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IPN.PA Yearly Shares OutstandingIPN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
IPN.PA Yearly Total Debt VS Total AssetsIPN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • IPN has an Altman-Z score of 5.03. This indicates that IPN is financially healthy and has little risk of bankruptcy at the moment.
  • IPN has a Altman-Z score of 5.03. This is in the better half of the industry: IPN outperforms 72.55% of its industry peers.
  • The Debt to FCF ratio of IPN is 1.18, which is an excellent value as it means it would take IPN, only 1.18 years of fcf income to pay off all of its debts.
  • IPN's Debt to FCF ratio of 1.18 is amongst the best of the industry. IPN outperforms 92.16% of its industry peers.
  • IPN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
  • IPN has a Debt to Equity ratio of 0.19. This is in the better half of the industry: IPN outperforms 76.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.18
Altman-Z 5.03
ROIC/WACC2.7
WACC7.98%
IPN.PA Yearly LT Debt VS Equity VS FCFIPN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.96 indicates that IPN should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.96, IPN is in the better half of the industry, outperforming 74.51% of the companies in the same industry.
  • A Quick Ratio of 1.79 indicates that IPN should not have too much problems paying its short term obligations.
  • IPN has a better Quick ratio (1.79) than 84.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.79
IPN.PA Yearly Current Assets VS Current LiabilitesIPN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. IPN.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 12.24% over the past year.
  • IPN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.79% yearly.
  • Looking at the last year, IPN shows a very strong growth in Revenue. The Revenue has grown by 64.12%.
  • Measured over the past years, IPN shows a small growth in Revenue. The Revenue has been growing by 5.83% on average per year.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%9.65%
Revenue 1Y (TTM)64.12%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%1.83%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.81% on average over the next years.
  • IPN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.47% yearly.
EPS Next Y10.9%
EPS Next 2Y9%
EPS Next 3Y7.04%
EPS Next 5Y6.81%
Revenue Next Year8.57%
Revenue Next 2Y9.25%
Revenue Next 3Y7.95%
Revenue Next 5Y6.47%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
IPN.PA Yearly Revenue VS EstimatesIPN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
IPN.PA Yearly EPS VS EstimatesIPN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. IPN.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • IPN is valuated correctly with a Price/Earnings ratio of 16.63.
  • 68.63% of the companies in the same industry are more expensive than IPN, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of IPN to the average of the S&P500 Index (26.78), we can say IPN is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 14.00, the valuation of IPN can be described as correct.
  • Based on the Price/Forward Earnings ratio, IPN is valued a bit cheaper than the industry average as 74.51% of the companies are valued more expensively.
  • IPN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.54.
Industry RankSector Rank
PE 16.63
Fwd PE 14
IPN.PA Price Earnings VS Forward Price EarningsIPN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IPN is valued cheaply inside the industry as 94.12% of the companies are valued more expensively.
  • 72.55% of the companies in the same industry are more expensive than IPN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.29
EV/EBITDA 6.19
IPN.PA Per share dataIPN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of IPN may justify a higher PE ratio.
PEG (NY)1.53
PEG (5Y)1.89
EPS Next 2Y9%
EPS Next 3Y7.04%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. IPN.PA Dividend Analysis

5.1 Amount

  • IPN has a yearly dividend return of 0.89%, which is pretty low.
  • Compared to an average industry Dividend Yield of 1.94, IPN has a dividend in line with its industry peers.
  • With a Dividend Yield of 0.89, IPN pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 0.89%

5.2 History

  • The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years2
Div Non Decr Years5
IPN.PA Yearly Dividends per shareIPN.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • IPN pays out 14.95% of its income as dividend. This is a sustainable payout ratio.
  • IPN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP14.95%
EPS Next 2Y9%
EPS Next 3Y7.04%
IPN.PA Yearly Income VS Free CF VS DividendIPN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M
IPN.PA Dividend Payout.IPN.PA Dividend Payout, showing the Payout Ratio.IPN.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IPN.PA Fundamentals: All Metrics, Ratios and Statistics

IPSEN

EPA:IPN (4/10/2026, 7:00:00 PM)

170.8

+8.1 (+4.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)07-29
Inst Owners15.77%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap14.31B
Revenue(TTM)5.87B
Net Income(TTM)777.50M
Analysts71.58
Price Target153.26 (-10.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.89%
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP14.95%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.45%
PT rev (3m)16.2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)9.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.64%
Revenue NY rev (3m)5.76%
Valuation
Industry RankSector Rank
PE 16.63
Fwd PE 14
P/S 2.44
P/FCF 17.29
P/OCF 12.38
P/B 3.3
P/tB 10.12
EV/EBITDA 6.19
EPS(TTM)10.27
EY6.01%
EPS(NY)12.2
Fwd EY7.14%
FCF(TTM)9.88
FCFY5.78%
OCF(TTM)13.8
OCFY8.08%
SpS70
BVpS51.74
TBVpS16.87
PEG (NY)1.53
PEG (5Y)1.89
Graham Number109.34
Profitability
Industry RankSector Rank
ROA 11.21%
ROE 17.93%
ROCE 27.02%
ROIC 21.54%
ROICexc 29.88%
ROICexgc 113.42%
OM 25.32%
PM (TTM) 13.25%
GM 81.66%
FCFM 14.11%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.38%
OM growth 5Y-1.48%
PM growth 3Y-18.1%
PM growth 5Y-11.16%
GM growth 3Y-0.97%
GM growth 5Y-0.21%
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.18
Debt/EBITDA 0.4
Cap/Depr 52.58%
Cap/Sales 5.6%
Interest Coverage 250
Cash Conversion 54.79%
Profit Quality 106.48%
Current Ratio 1.96
Quick Ratio 1.79
Altman-Z 5.03
F-Score7
WACC7.98%
ROIC/WACC2.7
Cap/Depr(3y)123.84%
Cap/Depr(5y)123.25%
Cap/Sales(3y)11.93%
Cap/Sales(5y)11.8%
Profit Quality(3y)111.08%
Profit Quality(5y)104.31%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%9.65%
EPS Next Y10.9%
EPS Next 2Y9%
EPS Next 3Y7.04%
EPS Next 5Y6.81%
Revenue 1Y (TTM)64.12%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%1.83%
Revenue Next Year8.57%
Revenue Next 2Y9.25%
Revenue Next 3Y7.95%
Revenue Next 5Y6.47%
EBIT growth 1Y87.65%
EBIT growth 3Y3.94%
EBIT growth 5Y6.31%
EBIT Next Year33.03%
EBIT Next 3Y12.65%
EBIT Next 5Y10.42%
FCF growth 1Y522.48%
FCF growth 3Y4.75%
FCF growth 5Y5.6%
OCF growth 1Y26.34%
OCF growth 3Y5.92%
OCF growth 5Y8.44%

IPSEN / IPN.PA Fundamental Analysis FAQ

What is the fundamental rating for IPN stock?

ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.


What is the valuation status for IPN stock?

ChartMill assigns a valuation rating of 5 / 10 to IPSEN (IPN.PA). This can be considered as Fairly Valued.


What is the profitability of IPN stock?

IPSEN (IPN.PA) has a profitability rating of 6 / 10.


How financially healthy is IPSEN?

The financial health rating of IPSEN (IPN.PA) is 7 / 10.


Can you provide the expected EPS growth for IPN stock?

The Earnings per Share (EPS) of IPSEN (IPN.PA) is expected to grow by 10.9% in the next year.